Download PDF
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis
Xuanwei Li; Wenlai Li; Yue Li; Chuanjiang Dong; Ping Zhu;
Nefrologia (English Version). 2023;43:731-41
Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020
Elisabet Ars; Carmen Bernis; Gloria Fraga; Mónica Furlano; Víctor Martínez; Judith Martins; Alberto Ortiz; Maria Vanessa Pérez-Gómez; José Carlos Rodríguez-Pérez; Laia Sans; Roser Torra;
Nefrologia (English Version). 2022;42:367-89
Tolvaptan-related toxicoderma
Alba Rivas Oural; Jose Joaquín Bande Fernández; Luis Fernando Morán Fernández; Sheila Requena López; Blanca Vivanco Allende; Elena Astudillo Cortés;
Nefrologia (English Version). 2024;44:597-9